Since the intracellular Aβ numbers were not increased, these results suggest that even though TNF-ɑ treatment can increase Aβ production in non-Alzheimer’s disease neurons, these aggregates can be cleared, as the clearance mechanisms of the cells are not yet exhausted. The gene discussed is TNF; the disease is early-onset autosomal dominant Alzheimer disease.